WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007022239) PHARMACEUTICAL FORMULATIONS FOR SUSTAINED DRUG DELIVERY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/022239    International Application No.:    PCT/US2006/031938
Publication Date: 22.02.2007 International Filing Date: 15.08.2006
IPC:
A61K 47/48 (2006.01), A61P 43/00 (2006.01)
Applicants: PRAECIS PHARMACEUTICALS, INC. [US/US]; 830 Winter Street, Waltham, MA 02451-1420 (US) (For All Designated States Except US).
MUSSO, Gary, F. [US/US]; (US) (For US Only).
BARKER, Nicholas [GB/US]; (US) (For US Only).
WOLFE, Janet, L. [US/US]; (US) (For US Only).
YE, Ming [US/US]; (US) (For US Only)
Inventors: MUSSO, Gary, F.; (US).
BARKER, Nicholas; (US).
WOLFE, Janet, L.; (US).
YE, Ming; (US)
Agent: DECONTI, Giulio, A.; Lahive & Cockfield, LLP, One Post Office Square, Boston, MA 02109-2127 (US)
Priority Data:
11/205,292 15.08.2005 US
11/265,553 02.11.2005 US
Title (EN) PHARMACEUTICAL FORMULATIONS FOR SUSTAINED DRUG DELIVERY
(FR) FORMULATIONS PHARMACEUTIQUES UTILES POUR L'APPORT CONTINU D'UN MEDICAMENT
Abstract: front page image
(EN)The present invention provides pharmaceutical formulations comprising a solid ionic complex of a polypeptide having an isoelectric point lower than physiological pH and an anionic carrier molecule. The formulations of the invention are suitable as depot formulations for the sustained release of therapeutic polypeptides.
(FR)La présente invention concerne des formulations pharmaceutiques qui renferment un complexe ionique solide d'un polypeptide dont le point isoélectrique est inférieur au pH physiologique et d'une molécule vecteur anionique. Les formulations selon l'invention sont appropriées en tant que formulations sous forme de dépôt assurant l'apport continu de polypeptides thérapeutiques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)